Cargando…

Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm

Polymyxin B is used as an antibiotic of last resort for patients with multidrug-resistant Gram-negative bacterial infections; however, it carries a significant risk of nephrotoxicity. Herein we present a polymyxin B therapeutic window based on target area under the concentration-time curve (AUC) val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakota, Elizabeth A., Landersdorfer, Cornelia B., Nation, Roger L., Li, Jian, Kaye, Keith S., Rao, Gauri G., Forrest, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Clinical Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021635/ https://www.ncbi.nlm.nih.gov/pubmed/29760144 http://dx.doi.org/10.1128/AAC.00483-18

Ejemplares similares

Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
por: Bergen, Phillip J., et al.
Publicado: (2015)

Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206
por: Bruss, Jon, et al.
Publicado: (2021)

Mortality, clinical and microbiological response following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections (a meta-analysis dataset)
por: Agyeman, Akosua A., et al.
Publicado: (2019)

Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward
por: Landersdorfer, Cornelia B., et al.
Publicado: (2021)

Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
por: Nation, Roger L., et al.
Publicado: (2019)

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B
por: Krzyzanski, Wojciech, et al.
Publicado: (2017)

Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
por: Lin, Yu-Wei, et al.
Publicado: (2019)

Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data
por: Lakota, Elizabeth A., et al.
Publicado: (2018)

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
por: Biagi, M., et al.
Publicado: (2020)

Efficacy and safety of ceftazidime–avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis
por: Yang, Ping, et al.
Publicado: (2023)

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
por: Abboud, Cely Saad, et al.
Publicado: (2014)

Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases
por: Olsson, Anna, et al.
Publicado: (2021)

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2016)

Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens
por: Cheah, Soon-Ee, et al.
Publicado: (2016)

Design and Evaluation of Novel Polymyxin Fluorescent Probes
por: Yun, Bo, et al.
Publicado: (2017)

An Open‐Label Dose‐Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2017)

Shifting Gears: The Future of Polymyxin Antibiotics
por: Lenhard, Justin R., et al.
Publicado: (2019)

Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey
por: Gallo, Marco, et al.
Publicado: (2015)

Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
por: Tran, Thien B., et al.
Publicado: (2015)

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata
por: Bader, Justin C., et al.
Publicado: (2018)

Oral Therapeutics Post Menopausal Osteoporosis
por: Schroeder, Ryan J, et al.
Publicado: (2023)

Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling
por: Rees, Vanessa E., et al.
Publicado: (2019)

Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy
por: Kim, Yoon-Myung, et al.
Publicado: (2020)

Dose‐Response Analysis of the Effect of Carbidopa‐Levodopa Extended‐Release Capsules (IPX066) in Levodopa‐Naive Patients With Parkinson Disease
por: Mao, Zhongping Lily, et al.
Publicado: (2016)

Deep learning–based 4D‐synthetic CTs from sparse‐view CBCTs for dose calculations in adaptive proton therapy
por: Thummerer, Adrian, et al.
Publicado: (2022)

For Personality Disorders
por: Treasure, J.
Publicado: (2022)

Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus
por: Zhao, Jinxin, et al.
Publicado: (2016)

Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
por: Velkov, Tony, et al.
Publicado: (2014)

707. QPX9003: Pharmacology of a Novel Polymyxin in Mice and Rats
por: Sabet, Mojgan, et al.
Publicado: (2019)

An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
por: Morén, Björn, et al.
Publicado: (2019)

A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Luterbach, Courtney L., et al.
Publicado: (2022)

Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria
por: Deris, Zakuan Z., et al.
Publicado: (2014)

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents
por: Chatelut, E, et al.
Publicado: (2012)

Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
por: Felton, T. W., et al.
Publicado: (2014)

Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy
por: Thomas, Christopher, et al.
Publicado: (2022)

Accuracy of dose‐volume metric calculation for small‐volume radiosurgery targets
por: Stanley, Dennis N., et al.
Publicado: (2021)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

How to calculate the dose of chemotherapy
por: Gurney, H
Publicado: (2002)

Daily Dosing for Bedaquiline in Patients with Tuberculosis
por: Salinger, David H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9t6kh0nabs6a6fkbfbt7g70ecj